Steve Bloor

Steve has over 25 years’ experience in the medical device and regenerative medicine industry. He has worked in US ultinationals (J&J, Covidien) and UK start-up companies, with specific expertise in leadership roles. strategic R&D, clinical compliance and regulation. Steve was formerly CSO at Tissue Science Laboratories and was behind the development of TSL’s tissue replacement technology. He subsequently became VP of R&D at Covidien following their $80m acquisition of TSL in 2008.